US Broker Ratings

Integra LifeSciences Holdings (IART) Stock Analysis: Exploring a 38.77% Potential Upside in a Challenging Market

Integra LifeSciences Holdings Corporation (NASDAQ: IART) stands as a significant player in the healthcare sector, particularly within the specialized field of medical devices. Headquartered in Princeton,..

NovoCure Limited (NVCR) Stock Analysis: Exploring A 96% Potential Upside Despite Current Challenges

NovoCure Limited (NASDAQ: NVCR), a pioneering company in the healthcare sector, focuses on innovative medical devices aimed at treating solid tumor cancers. Based in Baar, Switzerland,..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Uncertain Waters with a 13.73% Upside Potential

Teladoc Health, Inc. (NYSE: TDOC), a prominent player in the healthcare sector, is a pioneer in virtual healthcare services. The company has carved a niche in..

National HealthCare Corporation (NHC): Revenue Growth and Dividend Insights for Investors

National HealthCare Corporation (NYSE: NHC), a prominent player in the healthcare sector, stands out with its impressive revenue growth and stable dividend yield amidst a challenging..

Bausch Health Companies Inc. (BHC) Stock Analysis: Navigating a 16% Potential Upside and Market Challenges

Bausch Health Companies Inc. (NYSE: BHC) stands as a key player in the healthcare sector, specifically in the drug manufacturing industry focusing on specialty and generic..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Strong Revenue Growth and 22.92% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) stands as a noteworthy player in the healthcare sector, specializing in the development, manufacturing, and marketing of both branded and generic..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Unveiling a 187% Potential Upside with Promising Biotech Innovations

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology industry, is catching the attention of investors with its innovative approaches to treating severe inflammatory,..

GeneDx Holdings Corp. (WGS) Stock Report: Riding High on 39.6% Revenue Growth in the Genomics Sector

GeneDx Holdings Corp. (NASDAQ: WGS) has emerged as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization..

Harrow, Inc. (HROW) Stock Analysis: Robust Analyst Ratings Signal 83.5% Potential Upside

For investors eyeing opportunities in the healthcare sector, Harrow, Inc. (NASDAQ: HROW) offers an intriguing proposition. Specializing in ophthalmic pharmaceutical products, Harrow has captured the attention..

CG Oncology, Inc. (CGON) Stock Analysis: A 135% Potential Upside in the Biotech Sector

Investors with a keen interest in the biotechnology sector might find CG Oncology, Inc. (NASDAQ: CGON) an intriguing opportunity, bolstered by a remarkable potential upside of..

Indivior PLC (INDV) Stock Analysis: Evaluating Growth Potential with a 5.14% Upside

Indivior PLC (INDV) stands as a noteworthy player in the healthcare sector, focusing on the crucial field of substance use disorder treatment. With a market capitalization..

Artivion, Inc. (AORT) Stock Analysis: Healthcare Innovator with a Strong Buy Consensus and Strategic Growth Potential

Artivion, Inc. (NASDAQ: AORT), a prominent player in the healthcare sector, particularly within the medical devices industry, is currently drawing considerable attention from investors. With a..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Biotech Innovator with Promising Buy Ratings

Dyne Therapeutics, Inc. (NASDAQ: DYN) is making waves in the biotechnology sector with its focus on cutting-edge therapeutics for neuromuscular diseases. With a market capitalization of..

U.S. Physical Therapy, Inc. (USPH) Investor Outlook: Analyzing a 40% Potential Upside

U.S. Physical Therapy, Inc. (NYSE: USPH) presents an intriguing investment opportunity in the healthcare sector, particularly for those eyeing the medical care facilities industry. With a..

Novavax, Inc. (NVAX) Growth Potential: Analyzing the Surging Revenue and Future Prospects

As investors seek opportunities in the ever-evolving biotechnology sector, Novavax, Inc. (NASDAQ: NVAX) emerges as a captivating candidate for those with an appetite for high-growth potential...

Certara, Inc. (CERT) Stock Analysis: Exploring a 50% Upside Potential in the Healthcare Tech Sector

Certara, Inc. (NASDAQ: CERT), a key player in the healthcare technology landscape, is attracting significant attention from investors, thanks to its potential upside of over 50%...

Structure Therapeutics Inc. (GPCR): A Biotech with a Remarkable 245% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR), a dynamic player in the biotechnology sector, is capturing investor attention with its ambitious pipeline and significant potential upside. The company,..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Assessing the 11.43% Potential Upside in the Healthcare Sector

Brookdale Senior Living Inc. (NYSE: BKD) presents a compelling investment opportunity in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Brentwood, Tennessee,..

Vera Therapeutics, Inc. (VERA) Stock Analysis: A Biotech Gem with a 192.64% Potential Upside

Vera Therapeutics, Inc. (NASDAQ: VERA) is capturing investor attention with its promising pipeline in the biotechnology sector and an impressive potential upside of 192.64%. As a..

Addus HomeCare Corporation (ADUS): Investor Outlook Reveals 20.75% Potential Upside

Addus HomeCare Corporation (NASDAQ: ADUS) stands out in the healthcare sector with a compelling case for investors seeking opportunities in the medical care facilities industry. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds